Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea

Dadkhahfar, Sahar; Kani, Zahra Asadi; Araghi, Farnaz; Moravvej, Hamideh

doi:10.1002/ccr3.2776

Cited by 2 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All patients exhibited characteristic skin lesions and a potential systemic involvement was evaluated. We identified four case reports [1,[8][9][10], and together with the case from our institution, a total number of five patients with nodular/keloidal scleroderma. Significant clinical and serological information is summarized in Table 1.…”

Section: Discussionmentioning

confidence: 99%

Nodular/Keloidal Scleroderma with No Systemic Involvement—A Case Report and a Review of the Literature

Trufin,

Ungureanu,

Halmágyi

et al. 2024

JCM

View full text Add to dashboard Cite

Nodular or keloidal scleroderma is a rare condition with unclear cause and sporadic mentions in the medical literature. It was first recognized in the 19th century, yet its classification is still debated due to the limited number of reported cases. This rare variant of scleroderma is associated with either progressive systemic sclerosis or localized morphea. Clinically, it presents with asymptomatic nodules or plaques, resembling spontaneous keloid formation, often found on the trunk and proximal extremities. Recent literature reviews show a predominance of women with a mean age of 44 years. Diagnosis relies on clinical and histopathological findings, which usually show overlapping features of both scleroderma and true keloids, secondarily to an excessive fibrosing reaction attributed to collagen formation. We present an unusual case of a 70-year-old female patient who displayed the coexistence of two distinct subtypes of morphea (nodular/keloidal and linear), and exclusive skin involvement, which contrasts with the typical presentation of nodular/keloidal scleroderma, often associated with organ-specific disease. However, recent publications have diverged from previous ones regarding systemic sclerosis, with no systemic involvement reported between 2018 and 2024, which we evaluated in our descriptive literature review. With less than 50 cases reported in total, our case underlines the importance of recognizing this rare disease, ensuring appropriate evaluation, treatment, and follow-up.

show abstract

Section: Discussionmentioning

confidence: 99%

Nodular/Keloidal Scleroderma with No Systemic Involvement—A Case Report and a Review of the Literature

Trufin,

Ungureanu,

Halmágyi

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

“…However, 1 case of recalcitrant NS following cyclosporine treatment has been reported. 15 Oral Phosphodiesterase 4 inhibitors as an emerging treatment have shown promise; nonetheless, more evidence is required. 16 …”

Section: Discussionmentioning

confidence: 99%